-
1
-
-
0001363461
-
Epstein-Barr virus and human malignancies
-
Henle, W. and Henle, G., Epstein-Barr virus and human malignancies. Adv. Viral Oncol. 1985. 5: 201-238.
-
(1985)
Adv. Viral Oncol.
, vol.5
, pp. 201-238
-
-
Henle, W.1
Henle, G.2
-
2
-
-
0025353147
-
High incidence of Epstein-Barr virus genomes in Hodgkin's disease
-
Herbst, H., Niedobitek, G., Kneba, M., Hummel, M., Finn, T., Anagnostopuolos, I., Bergholz, M., Krieger, G. and Stein, H., High incidence of Epstein-Barr virus genomes in Hodgkin's disease. Am. J. Pathol. 1990. 137: 13-18.
-
(1990)
Am. J. Pathol.
, vol.137
, pp. 13-18
-
-
Herbst, H.1
Niedobitek, G.2
Kneba, M.3
Hummel, M.4
Finn, T.5
Anagnostopuolos, I.6
Bergholz, M.7
Krieger, G.8
Stein, H.9
-
3
-
-
0022263464
-
Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation
-
Hanto, D. W., Frizzera, G., Gajl-Peczalska, K. J. and Simmons, R. L., Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation 1985. 39: 461-472.
-
(1985)
Transplantation
, vol.39
, pp. 461-472
-
-
Hanto, D.W.1
Frizzera, G.2
Gajl-Peczalska, K.J.3
Simmons, R.L.4
-
4
-
-
0000462866
-
Epstein-Barr virus and its replication
-
Fields, F. M. and Knipe, D. N. (Eds.) Raven Press, New York
-
Kieff, E. and Leibowitz, D., Epstein-Barr virus and its replication. In Fields, F. M. and Knipe, D. N. (Eds.) Immunology, 2nd Edn. Raven Press, New York 1990, pp 1889-1920.
-
(1990)
Immunology, 2nd Edn.
, pp. 1889-1920
-
-
Kieff, E.1
Leibowitz, D.2
-
5
-
-
0019500668
-
Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell line
-
Rickinson, A. B., Moss, D. J., Allen, D. J., Wallace, L. E., Rowe, M. and Epstein, M. A., Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell line. Int. J. Cancer 1981. 27: 593-601.
-
(1981)
Int. J. Cancer
, vol.27
, pp. 593-601
-
-
Rickinson, A.B.1
Moss, D.J.2
Allen, D.J.3
Wallace, L.E.4
Rowe, M.5
Epstein, M.A.6
-
6
-
-
0030018397
-
Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides
-
Reali, E., Guerrini, R., Giori, B., Borghi, M., Marastoni, M., Tomatis, R., Traniello, S., Masucci, M. G. and Gavioli, R., Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides. Clin. Exp. Immunol. 1996. 105: 369-375.
-
(1996)
Clin. Exp. Immunol.
, vol.105
, pp. 369-375
-
-
Reali, E.1
Guerrini, R.2
Giori, B.3
Borghi, M.4
Marastoni, M.5
Tomatis, R.6
Traniello, S.7
Masucci, M.G.8
Gavioli, R.9
-
7
-
-
0029929419
-
A recombinant adenovirus expressing an Epstein-Barr virus (EBV) target antigen can selectively reactivate rare components of EBV cytotoxic T-lymphocyte memory in vitro
-
Morgan, S. M., Wilkinson, G. W., Floettmann, E., Blake, N. and Rickinson, A. B., A recombinant adenovirus expressing an Epstein-Barr virus (EBV) target antigen can selectively reactivate rare components of EBV cytotoxic T-lymphocyte memory in vitro. J. Virol. 1996. 70: 2394-2402.
-
(1996)
J. Virol.
, vol.70
, pp. 2394-2402
-
-
Morgan, S.M.1
Wilkinson, G.W.2
Floettmann, E.3
Blake, N.4
Rickinson, A.B.5
-
8
-
-
0029758077
-
Polymorphonuclear neutrophils pulsed with synthetic peptides efficiently activate memory cytotoxic T lymphocytes
-
Reali, E., Guerrini, R., Moretti, S., Spisani, S., Lanza, F., Tomatis, R., Traniello, S. and Gavioli, R., Polymorphonuclear neutrophils pulsed with synthetic peptides efficiently activate memory cytotoxic T lymphocytes. J. Leukoc. Biol. 1996. 60: 207-213.
-
(1996)
J. Leukoc. Biol.
, vol.60
, pp. 207-213
-
-
Reali, E.1
Guerrini, R.2
Moretti, S.3
Spisani, S.4
Lanza, F.5
Tomatis, R.6
Traniello, S.7
Gavioli, R.8
-
9
-
-
0026734842
-
Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): Implications for the immune control of EBV-positive malignancies
-
Murray, R. J., Kurilla, M. G., Brooks, J. M., Thomas, W. A., Rowe, M., Kieff, E. and Rickinson, A. B., Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J. Exp. Med. 1992. 176: 157-168.
-
(1992)
J. Exp. Med.
, vol.176
, pp. 157-168
-
-
Murray, R.J.1
Kurilla, M.G.2
Brooks, J.M.3
Thomas, W.A.4
Rowe, M.5
Kieff, E.6
Rickinson, A.B.7
-
10
-
-
0026681729
-
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: Implications for vaccine development
-
Khanna, R., Burrows, S. R., Kurilla, M. G., Jacob, C. A., Misko, I. S., Sculley, T. B., Kieff, E. and Moss, D. J., Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: Implications for vaccine development. J. Exp. Med. 1992. 176: 169-176.
-
(1992)
J. Exp. Med.
, vol.176
, pp. 169-176
-
-
Khanna, R.1
Burrows, S.R.2
Kurilla, M.G.3
Jacob, C.A.4
Misko, I.S.5
Sculley, T.B.6
Kieff, E.7
Moss, D.J.8
-
11
-
-
0027464975
-
Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4
-
Gavioli, R., Kurilla, M. G., de Campos-Lima, P. O., Wallace, L. E., Dolcetti, R., Murray, R. J., Rickinson, A. B. and Masucci, M. G., Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. J. Virol. 1993. 67: 1572-1578.
-
(1993)
J. Virol.
, vol.67
, pp. 1572-1578
-
-
Gavioli, R.1
Kurilla, M.G.2
De Campos-Lima, P.O.3
Wallace, L.E.4
Dolcetti, R.5
Murray, R.J.6
Rickinson, A.B.7
Masucci, M.G.8
-
12
-
-
0031113988
-
Conserved CTL epitopes within EBV latent membrane protein 2: A potential target for CTL-based tumor therapy
-
Lee, S. P., Tierney, R. J., Thomas, W. A., Brooks, J. M. and Rickinson, A. B., Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy. J. Immunol. 1997. 158: 3325-3334.
-
(1997)
J. Immunol.
, vol.158
, pp. 3325-3334
-
-
Lee, S.P.1
Tierney, R.J.2
Thomas, W.A.3
Brooks, J.M.4
Rickinson, A.B.5
-
13
-
-
0030889206
-
Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection
-
Rickinson, A. B. and Moss, D. J., Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu. Rev. Immunol. 1997. 15: 405-431.
-
(1997)
Annu. Rev. Immunol.
, vol.15
, pp. 405-431
-
-
Rickinson, A.B.1
Moss, D.J.2
-
14
-
-
0029003999
-
Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1
-
Levitskaya, J., Coram, M., Levitsky, V., Imreh, S., Steigerwald-Mullen, P. M., Klein, G., Kurilla, M. G. and Masucci, M. G., Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 1995. 375: 685-688.
-
(1995)
Nature
, vol.375
, pp. 685-688
-
-
Levitskaya, J.1
Coram, M.2
Levitsky, V.3
Imreh, S.4
Steigerwald-Mullen, P.M.5
Klein, G.6
Kurilla, M.G.7
Masucci, M.G.8
-
15
-
-
0031414705
-
+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing
-
+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing. Immunity 1997. 7: 791-802.
-
(1997)
Immunity
, vol.7
, pp. 791-802
-
-
Blake, N.1
Lee, S.2
Redchenko, I.3
Thomas, W.4
Steven, N.5
Leese, A.6
Steigerwald-Mullen, P.7
Kurilla, M.G.8
Frappier, L.9
Rickinson, A.10
-
16
-
-
0026029532
-
Expression of Epstein-Barr virus-encoded growth-transformation-associated proteins in lymphoproliferations of bone-marrow transplant recipients
-
Gratama, J. W., Zutter, M. M., Minarovits, J., Oosterveer, M. A., Thomas, E. D., Klein, G. and Ernberg, I., Expression of Epstein-Barr virus-encoded growth-transformation-associated proteins in lymphoproliferations of bone-marrow transplant recipients. Int. J. Cancer 1991. 47: 188-192.
-
(1991)
Int. J. Cancer
, vol.47
, pp. 188-192
-
-
Gratama, J.W.1
Zutter, M.M.2
Minarovits, J.3
Oosterveer, M.A.4
Thomas, E.D.5
Klein, G.6
Ernberg, I.7
-
17
-
-
0028288519
-
Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation
-
Papadopulos, E. B., Ladanyi, M., Emanuel, D., Mackinnon, S., Boulad, F., Carabasi, M. H., Castro-Malaspina, H., Childs, B. H., Gillio, A. P., Small, T. N., Young, J. W., Kernan, N. A. and O'Reilly, R. J., Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N. Engl. J. Med. 1994. 330: 1185-1191.
-
(1994)
N. Engl. J. Med.
, vol.330
, pp. 1185-1191
-
-
Papadopulos, E.B.1
Ladanyi, M.2
Emanuel, D.3
Mackinnon, S.4
Boulad, F.5
Carabasi, M.H.6
Castro-Malaspina, H.7
Childs, B.H.8
Gillio, A.P.9
Small, T.N.10
Young, J.W.11
Kernan, N.A.12
O'Reilly, R.J.13
-
18
-
-
0028816546
-
Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation
-
Rooney, C. M., Smith, C. A., Ng, C. Y., Loftin, S., Li, C., Krance, R. A., Brenner, M. K. and Heslop, H. E., Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 1995. 345: 9-13.
-
(1995)
Lancet
, vol.345
, pp. 9-13
-
-
Rooney, C.M.1
Smith, C.A.2
Ng, C.Y.3
Loftin, S.4
Li, C.5
Krance, R.A.6
Brenner, M.K.7
Heslop, H.E.8
-
19
-
-
0029924619
-
Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes
-
Heslop, H. E., Ng, C. Y., Li, C., Smith, C. A., Loftin, S. K., Krance, R. A., Brenner, M. K. and Rooney, C. M., Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nature Med. 1996. 2: 551-555.
-
(1996)
Nature Med.
, vol.2
, pp. 551-555
-
-
Heslop, H.E.1
Ng, C.Y.2
Li, C.3
Smith, C.A.4
Loftin, S.K.5
Krance, R.A.6
Brenner, M.K.7
Rooney, C.M.8
-
20
-
-
0032526334
-
Reconstitution of EBV-specific T cell immunity in solid organ transplantation recipients
-
Haque, T, Amlot, P. L., Helling, N., Thomas, J. A., Sweny, P., Rolles, K., Burroughs, A. K., Prentice, H. G. and Crawford, D. H., Reconstitution of EBV-specific T cell immunity in solid organ transplantation recipients. J. Immunol. 1998. 160: 6204-6209.
-
(1998)
J. Immunol.
, vol.160
, pp. 6204-6209
-
-
Haque, T.1
Amlot, P.L.2
Helling, N.3
Thomas, J.A.4
Sweny, P.5
Rolles, K.6
Burroughs, A.K.7
Prentice, H.G.8
Crawford, D.H.9
-
21
-
-
0032170108
-
Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients
-
Rooney, C. M., Smith, C. A., Ng, C. Y., Loftin, S. K., Sixbey, J. W., Gan, Y., Srivastava, D. K., Bowman, L. C., Krance, R. A., Brenner, M. K. and Heslop, H. E., Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 1998. 92: 1549-1555.
-
(1998)
Blood
, vol.92
, pp. 1549-1555
-
-
Rooney, C.M.1
Smith, C.A.2
Ng, C.Y.3
Loftin, S.K.4
Sixbey, J.W.5
Gan, Y.6
Srivastava, D.K.7
Bowman, L.C.8
Krance, R.A.9
Brenner, M.K.10
Heslop, H.E.11
-
22
-
-
0030069315
-
Establishment of anti-Epstein-Barr virus (EBV) cellular immunity by adoptive transfer of virus-specific cytotoxic T lymphocytes from an HLA-matched sibling to a patient with severe chronic active EBV infection
-
Kuzushima, K., Yamamoto, M., Kimura, H., Ando, Y., Kudo, T., Tsuge, I. and Morishima, T., Establishment of anti-Epstein-Barr virus (EBV) cellular immunity by adoptive transfer of virus-specific cytotoxic T lymphocytes from an HLA-matched sibling to a patient with severe chronic active EBV infection. Clin. Exp. Immunol. 1996. 103: 192-198.
-
(1996)
Clin. Exp. Immunol.
, vol.103
, pp. 192-198
-
-
Kuzushima, K.1
Yamamoto, M.2
Kimura, H.3
Ando, Y.4
Kudo, T.5
Tsuge, I.6
Morishima, T.7
-
23
-
-
0032523173
-
Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease
-
Roskrow, M. A., Suzuki, N., Gan, Y., Sixbey, J. W., Ng, C. Y., Kimbrough, S., Hudson, M., Brenner, M. K., Heslop, H. E. and Rooney, C. M., Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease. Blood 1998. 91: 2925-2934.
-
(1998)
Blood
, vol.91
, pp. 2925-2934
-
-
Roskrow, M.A.1
Suzuki, N.2
Gan, Y.3
Sixbey, J.W.4
Ng, C.Y.5
Kimbrough, S.6
Hudson, M.7
Brenner, M.K.8
Heslop, H.E.9
Rooney, C.M.10
-
24
-
-
0026594257
-
Epstein-Barr virus latent gene transcription in nasopharingeal carcinoma cells: Coexpression of EBNA1, LMP1, and LMP2 transcripts
-
Brooks, L., Yao, Q. Y., Rickinson, A. B. and Young, L. S., Epstein-Barr virus latent gene transcription in nasopharingeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J. Virol. 1992. 66: 2689-2697.
-
(1992)
J. Virol.
, vol.66
, pp. 2689-2697
-
-
Brooks, L.1
Yao, Q.Y.2
Rickinson, A.B.3
Young, L.S.4
-
25
-
-
0026582459
-
Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharingeal carcinoma
-
Busson, P., McCoy, R., Sadler, R., Gilligan, K., Tursz, T. and Raab-Traub, N., Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharingeal carcinoma. J. Virol. 1992. 66: 3257-3262.
-
(1992)
J. Virol.
, vol.66
, pp. 3257-3262
-
-
Busson, P.1
McCoy, R.2
Sadler, R.3
Gilligan, K.4
Tursz, T.5
Raab-Traub, N.6
-
26
-
-
0025819202
-
Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells
-
Herbst, H., Dallenbach, F., Hummel, M., Niedobitek, G., Pileri, S., Müller-Lantzsch, N. and Stein, H., Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc. Natl. Acad. Sci. USA 1991. 88: 4766-4770.
-
(1991)
Proc. Natl. Acad. Sci. USA
, vol.88
, pp. 4766-4770
-
-
Herbst, H.1
Dallenbach, F.2
Hummel, M.3
Niedobitek, G.4
Pileri, S.5
Müller-Lantzsch, N.6
Stein, H.7
-
27
-
-
0029087498
-
Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease
-
Frisan, T., Sjoberg, J., Dolcetti, R., Boiocchi, M., De Re, V., Carbone, A., Brautbar, C., Battat, S., Biberfeld, P., Eckman, M., Ost, A., Christensson, B., Sundstrom, C., Bjorkholm, M., Pisa, P. and Masucci, M. G., Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease. Blood 1995. 86: 1493-1501.
-
(1995)
Blood
, vol.86
, pp. 1493-1501
-
-
Frisan, T.1
Sjoberg, J.2
Dolcetti, R.3
Boiocchi, M.4
De Re, V.5
Carbone, A.6
Brautbar, C.7
Battat, S.8
Biberfeld, P.9
Eckman, M.10
Ost, A.11
Christensson, B.12
Sundstrom, C.13
Bjorkholm, M.14
Pisa, P.15
Masucci, M.G.16
-
28
-
-
0029986054
-
Frequent expression of interleukin-10 by Epstein-Barr virus harboring tumor cells of Hodgkin's disease
-
Herbst, H., Foss, H. d., Samol, J., Araujo, I., Klotzbach, H., Krause, H., Agathanggelou, A., Niedobitek, G. and Stein, H., Frequent expression of interleukin-10 by Epstein-Barr virus harboring tumor cells of Hodgkin's disease. Blood 1996. 87: 2918-2929.
-
(1996)
Blood
, vol.87
, pp. 2918-2929
-
-
Herbst, H.1
Foss, H.D.2
Samol, J.3
Araujo, I.4
Klotzbach, H.5
Krause, H.6
Agathanggelou, A.7
Niedobitek, G.8
Stein, H.9
-
29
-
-
0027365433
-
HLa A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2
-
Lee, S. P., Thomas, W. A., Murray, R. J., Khanim, F., Kaur, S., Young, L. S., Rowe, M., Kurilla, M. and Rickinson, A. B., HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2. J. Virol. 1993. 67: 7428-7435.
-
(1993)
J. Virol.
, vol.67
, pp. 7428-7435
-
-
Lee, S.P.1
Thomas, W.A.2
Murray, R.J.3
Khanim, F.4
Kaur, S.5
Young, L.S.6
Rowe, M.7
Kurilla, M.8
Rickinson, A.B.9
-
30
-
-
0026317416
-
The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2
-
Bednarek, M. A., Sauma, S. Y., Gammon, M. C., Porter, G., Tamhankar, S., Williamson, A. R. and Zweerink, H., The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2. J. Immunol. 1991. 147: 4047-4053.
-
(1991)
J. Immunol.
, vol.147
, pp. 4047-4053
-
-
Bednarek, M.A.1
Sauma, S.Y.2
Gammon, M.C.3
Porter, G.4
Tamhankar, S.5
Williamson, A.R.6
Zweerink, H.7
-
31
-
-
0027304399
-
Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules
-
Ruppert, J., Sidney, J., Celis, E., Kubo, R. T., Grey, H. M. and Sette, A., Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 1993. 74: 929-937.
-
(1993)
Cell
, vol.74
, pp. 929-937
-
-
Ruppert, J.1
Sidney, J.2
Celis, E.3
Kubo, R.T.4
Grey, H.M.5
Sette, A.6
-
32
-
-
0028052724
-
Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains
-
Parker, K. C., Bednarek, M. A. and Coligan, J. E., Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 1994. 152: 163-175.
-
(1994)
J. Immunol.
, vol.152
, pp. 163-175
-
-
Parker, K.C.1
Bednarek, M.A.2
Coligan, J.E.3
-
33
-
-
0029043041
-
Detailed motifs for peptide binding to HLA-A0201 derived from large random sets of peptides using a cellular binding assay
-
Drijfhout, J. W., Brandt, R. M. P., D'Amaro, J., Kast, W. M. and Melief, C. J., Detailed motifs for peptide binding to HLA-A0201 derived from large random sets of peptides using a cellular binding assay. Hum. Immunol. 1995. 43: 1-12.
-
(1995)
Hum. Immunol.
, vol.43
, pp. 1-12
-
-
Drijfhout, J.W.1
Brandt, R.M.P.2
D'Amaro, J.3
Kast, W.M.4
Melief, C.J.5
-
34
-
-
0029811941
-
Transporter (TAP)-independent processing of a multiple membrane-spanning protein, the Epstein-Barr virus latent membrane protein 2
-
Lee, S. P., Thomas, W. A., Blake, N. W. and Rickinson, A. B., Transporter (TAP)-independent processing of a multiple membrane-spanning protein, the Epstein-Barr virus latent membrane protein 2. Eur. J. Immunol. 1996. 26: 1875-1883.
-
(1996)
Eur. J. Immunol.
, vol.26
, pp. 1875-1883
-
-
Lee, S.P.1
Thomas, W.A.2
Blake, N.W.3
Rickinson, A.B.4
-
35
-
-
0030013725
-
Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: Implications for cytotoxic T-lymphocyte control of EBV-associated malignancies
-
Khanna, R., Burrows, S. R., Moss, D. J. and Silins, S. L., Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies. J. Virol. 1996. 70: 5357-5362.
-
(1996)
J. Virol.
, vol.70
, pp. 5357-5362
-
-
Khanna, R.1
Burrows, S.R.2
Moss, D.J.3
Silins, S.L.4
-
36
-
-
0027529512
-
The effect of anchor residue modifications on the stability of major histocompatibiliy complex class I-peptide interactions
-
Neefjes, J. J., Dierx, J. and Ploegh, H. L., The effect of anchor residue modifications on the stability of major histocompatibiliy complex class I-peptide interactions. Eur. J. Immunol. 1993. 23: 840-845.
-
(1993)
Eur. J. Immunol.
, vol.23
, pp. 840-845
-
-
Neefjes, J.J.1
Dierx, J.2
Ploegh, H.L.3
-
37
-
-
0029974607
-
Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability
-
van der Burg, S. H., Visseren, M. J., Brandt, R. M., Kast, W. M. and Melief, C. J., Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. J. Immunol. 1996. 156: 3308-3314.
-
(1996)
J. Immunol.
, vol.156
, pp. 3308-3314
-
-
Van Der Burg, S.H.1
Visseren, M.J.2
Brandt, R.M.3
Kast, W.M.4
Melief, C.J.5
-
38
-
-
0027983589
-
Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity an is strongly influenced by nondominant anchor residues
-
Chen, W., Khilko, S., Fecondo, J., Margulies, D. H. and McCluskey, J., Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity an is strongly influenced by nondominant anchor residues. J. Exp. Med. 1994. 180: 1471-1483.
-
(1994)
J. Exp. Med.
, vol.180
, pp. 1471-1483
-
-
Chen, W.1
Khilko, S.2
Fecondo, J.3
Margulies, D.H.4
McCluskey, J.5
-
39
-
-
0029920909
-
The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4
-
Levitsky, V., Zhang, Q. J., Levitskaya, J. and Masucci, M. G., The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4. J. Exp. Med. 1996. 183: 915-926.
-
(1996)
J. Exp. Med.
, vol.183
, pp. 915-926
-
-
Levitsky, V.1
Zhang, Q.J.2
Levitskaya, J.3
Masucci, M.G.4
-
40
-
-
0031229803
-
Chimeric peptides: A new approach to enhancing the immunogenicity of peptides with low MHC class I affinity: Application in antiviral vaccination
-
Tourdot, S., Oukka, M., Manuguerra, J. C., Magafa, V., Vergnon, I., Riche, N., Bruley-Rosset, M., Cordopatis, P. and Kosmatopoulos, K., Chimeric peptides: a new approach to enhancing the immunogenicity of peptides with low MHC class I affinity: application in antiviral vaccination. J. Immunol. 1997. 159: 2391-2398.
-
(1997)
J. Immunol.
, vol.159
, pp. 2391-2398
-
-
Tourdot, S.1
Oukka, M.2
Manuguerra, J.C.3
Magafa, V.4
Vergnon, I.5
Riche, N.6
Bruley-Rosset, M.7
Cordopatis, P.8
Kosmatopoulos, K.9
-
41
-
-
0028964889
-
Peptide engineering allows cytotoxic T-cell vaccination against human papilloma virus tumour antigen, E6
-
Lipford, G. B., Bauer, S., Wagner, H. and Heeg, K., Peptide engineering allows cytotoxic T-cell vaccination against human papilloma virus tumour antigen, E6. Immunology 1995. 84: 298-303.
-
(1995)
Immunology
, vol.84
, pp. 298-303
-
-
Lipford, G.B.1
Bauer, S.2
Wagner, H.3
Heeg, K.4
-
42
-
-
0029152771
-
Amino-terminal alteration of the HLA-A0201-restricted human immunodeficiency virus pol peptide increases complex stability and in vitro immunogenicity
-
Pogue, R. R., Eron, J., Frelinger, J. A. and Matsui, M., Amino-terminal alteration of the HLA-A0201-restricted human immunodeficiency virus pol peptide increases complex stability and in vitro immunogenicity. Proc. Natl. Acad. Sci. USA 1995. 92: 8166-8170.
-
(1995)
Proc. Natl. Acad. Sci. USA
, vol.92
, pp. 8166-8170
-
-
Pogue, R.R.1
Eron, J.2
Frelinger, J.A.3
Matsui, M.4
-
43
-
-
0031852722
-
gp100/pmel 17 is a murine rejection antigen: Induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand
-
Overwijk, W. W., Tsung, A., Irvine, K. R., Parkhurst, M. R., Goletz, T. J., Tsung, K., Carrol, M. W., Liu, C., Moss, B., Rosemberg, S. A. and Restifo, N. P., gp100/pmel 17 is a murine rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand. J. Exp. Med. 1998. 188: 277-286.
-
(1998)
J. Exp. Med.
, vol.188
, pp. 277-286
-
-
Overwijk, W.W.1
Tsung, A.2
Irvine, K.R.3
Parkhurst, M.R.4
Goletz, T.J.5
Tsung, K.6
Carrol, M.W.7
Liu, C.8
Moss, B.9
Rosemberg, S.A.10
Restifo, N.P.11
-
44
-
-
0027411777
-
An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins
-
Zhang, Q. J., Gavioli, R., Klein, G. and Masucci, M. G., An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins. Proc. Natl. Acad. Sci. USA 1993. 90: 2217-2221.
-
(1993)
Proc. Natl. Acad. Sci. USA
, vol.90
, pp. 2217-2221
-
-
Zhang, Q.J.1
Gavioli, R.2
Klein, G.3
Masucci, M.G.4
-
45
-
-
0032914970
-
A single specific amino acid residue in peptide antigens is sufficient to activate memory cytotoxic T lymphocytes; potential role of cross-reactive peptides in memory T cell maintenance
-
Reali, E., Guerrini, R., Marastoni, M., Tomatis, R., Masucci, M. G., Traniello, S. and Gavioli, R., A single specific amino acid residue in peptide antigens is sufficient to activate memory cytotoxic T lymphocytes; potential role of cross-reactive peptides in memory T cell maintenance. J. Immunol. 1999. 162: 106-113.
-
(1999)
J. Immunol.
, vol.162
, pp. 106-113
-
-
Reali, E.1
Guerrini, R.2
Marastoni, M.3
Tomatis, R.4
Masucci, M.G.5
Traniello, S.6
Gavioli, R.7
-
46
-
-
0028857377
-
Effect of anchor residue modifications on the stability of HLA-A11/peptide complexes
-
Gavioli, R., Zhang, Q. J., Marastoni, M., Guerrini, R., Reali, E., Tomatis, R., Masucci, M. G. and Traniello, S., Effect of anchor residue modifications on the stability of HLA-A11/peptide complexes. Biochem. Biophys. Res. Commun. 1995. 206: 8-14.
-
(1995)
Biochem. Biophys. Res. Commun.
, vol.206
, pp. 8-14
-
-
Gavioli, R.1
Zhang, Q.J.2
Marastoni, M.3
Guerrini, R.4
Reali, E.5
Tomatis, R.6
Masucci, M.G.7
Traniello, S.8
-
47
-
-
0032498111
-
High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexes
-
Gavioli, R., Guerrini, R., Masucci, M. G., Tomatis, R., Traniello, S. and Marastoni, M., High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexes. FEBS Lett. 1998. 421: 95-99.
-
(1998)
FEBS Lett.
, vol.421
, pp. 95-99
-
-
Gavioli, R.1
Guerrini, R.2
Masucci, M.G.3
Tomatis, R.4
Traniello, S.5
Marastoni, M.6
-
48
-
-
0026639647
-
Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA A11 restricted cytotoxic T lymphocytes: Implications for the down-regulation of HLA A11 in Burkitt's lymphoma
-
Gavioli, R., De Campos-Lima, P. O., Kurilla, M. G., Kieff, E., Klein, G. and Masucci, M. G., Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA A11 restricted cytotoxic T lymphocytes: Implications for the down-regulation of HLA A11 in Burkitt's lymphoma. Proc. Natl. Acad. Sci. USA 1992. 89: 5862-5866.
-
(1992)
Proc. Natl. Acad. Sci. USA
, vol.89
, pp. 5862-5866
-
-
Gavioli, R.1
De Campos-Lima, P.O.2
Kurilla, M.G.3
Kieff, E.4
Klein, G.5
Masucci, M.G.6
|